These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 5819165)

  • 1. The effects of phenphormin on blood fibrinolysis in diabetes mellitus.
    Fiaschi E; Barbui T; Previato G; Di Luzio V; Guarnieri GF; Todesco S
    Arzneimittelforschung; 1969 Apr; 19(4):638-40. PubMed ID: 5819165
    [No Abstract]   [Full Text] [Related]  

  • 2. [Initial results in the treatment of diabetes mellitus with an association of glibenclamide and phenformin].
    Carta Q; Pugliese F
    Minerva Med; 1974 Jan; 65(1):27-57. PubMed ID: 4214410
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various therapeutic prerogatives of phenethylbiguanide in diabete mellitus. Effect of the drug on body weight, blood cholesterol, fibrinolysis, and blood lactic acid].
    Previato G; Barbui T; Guarnieri GF; Di Luzio V; Padovan D
    Clin Ter; 1969 Jul; 50(1):27-36. PubMed ID: 5386586
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of phenformin plus stanozolol on fibrinolysis, platelet adhesiveness and blood lipids in patients with recurrent venous thrombosis.
    Bielawiec M; Myśliwiec M; Perzanowski A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(3):483-8. PubMed ID: 4139068
    [No Abstract]   [Full Text] [Related]  

  • 5. Hypocholesterolemic activity of colestipol in diabetes.
    Bandisode MS; Boshell BR
    Curr Ther Res Clin Exp; 1975 Aug; 18(2):276-84. PubMed ID: 809240
    [No Abstract]   [Full Text] [Related]  

  • 6. Prophylaxis of recurrent venous thrombosis with long-term enhancement of fibrinolysis.
    Bielawiec M; Lukjan H; Myśliwiec M; Dabrowski S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):971-6. PubMed ID: 94894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Daily curves of blood sugar and serum insulin after treatment with various combinations of glibenclamide and phenformin].
    Giangrandi E; Scaroina F; Tommasini-Degna C
    Minerva Med; 1975 Mar; 66(19):940-5. PubMed ID: 804684
    [No Abstract]   [Full Text] [Related]  

  • 8. Lactic acidosis in phenformin-treated diabetics. A clinical and laboratory study.
    Bengtsson K; Karlberg B; Lindgren S
    Acta Med Scand; 1972 Mar; 191(3):203-8. PubMed ID: 4624476
    [No Abstract]   [Full Text] [Related]  

  • 9. Antifibrin action of phenformin.
    Banerjee RN; Kumar V; Rao SR; Sahni AL; Arya M; Bardhan J
    Diabetologia; 1975 Apr; 11(2):105-11. PubMed ID: 1149944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The 131I-fibrinogen turnover during activation of blood fibrinolysis].
    Grabowski R; Bielawiec M; Kiersnowska B; Lukjan H; Perzanowski A; Mysliwiec M; Korfel B; Rogowski F
    Z Gesamte Inn Med; 1976 Dec; 31(24):1025-7. PubMed ID: 1020408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibrinolytic system and blood pressure in patients with hypertensive cardiovascular disease treated with reserpine and phenformin.
    Worowski K; Prokopowicz J; Gabryelewicz A
    Haematologia (Budap); 1970; 4(3):399-403. PubMed ID: 4256949
    [No Abstract]   [Full Text] [Related]  

  • 12. [Some advantages of the combination of phenformin and chlorpropamide in the therapy of diabetes mellitus].
    Naccarato R; Broglio G; Sirigu F; Previato G; Fameli O
    Policlinico Med; 1965 Dec; 72(6):401-14. PubMed ID: 5881467
    [No Abstract]   [Full Text] [Related]  

  • 13. [A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis].
    Dil'man VM; Riabov SI; Tsyrlina EV; Kirsanov AI; Kovaleva IG
    Vopr Onkol; 1972; 18(2):84-6. PubMed ID: 5012922
    [No Abstract]   [Full Text] [Related]  

  • 14. Phenformin hydrochloride (D.B.I.) in diabetes mellitus.
    Mitra PP; Sanyal DC
    Bull Calcutta Sch Trop Med; 1965 Oct; 13(4):145-6. PubMed ID: 5882336
    [No Abstract]   [Full Text] [Related]  

  • 15. Fibrinogen content and fibrinolytic activity of blood in diabetics, before and after antidiabetic drugs.
    Bedi HK; Vyas BR; Bomb BS; Agarwal ML; Bedi T
    J Assoc Physicians India; 1977 Mar; 25(3):181-5. PubMed ID: 914747
    [No Abstract]   [Full Text] [Related]  

  • 16. Phenformin effect on body weight, lipids, and glucose regulation.
    Alterman SL; Lopez-Gomez AA
    Ann N Y Acad Sci; 1968 Mar; 148(3):884-91. PubMed ID: 4872312
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes of the blood lipid pattern in diabetics under treatment with chlorpropamide and phenethyl-1-biguanide].
    Meduri D; Polito R
    Minerva Med; 1969 Jun; 60(49):2439-48. PubMed ID: 5802656
    [No Abstract]   [Full Text] [Related]  

  • 18. [Our experience with Daonil. A new oral hypoglycemic agent].
    Rodriguez-Miñon JL; Arrieta F; Herrera JL
    Diabete; 1970; 18(3):164-5. PubMed ID: 5472233
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral combination therapy in diabetes mellitus.
    Shah RJ; Shah RM
    Indian Pract; 1966 Aug; 19(8):569-77. PubMed ID: 5916115
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological fibrinolysis in diabetes mellitus.
    Chakrabarti R; Fearnley GR
    Diabetologia; 1974 Feb; 10(1):19-22. PubMed ID: 4835611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.